Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasms

Robert Peter Gale; Christophe Badie

doi:10.1038/s41375-025-02544-3

Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasms

Robert Peter Gale^*
, Christophe Badie

^*Corresponding author for this work

Radiation Effects

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1009-1010
Number of pages	2
Journal	Leukemia
Volume	39
Issue number	4
DOIs	https://doi.org/10.1038/s41375-025-02544-3
Publication status	Published - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41375-025-02544-3

Cite this

@article{09ea1c7d616e41b1850fa3de0128bb0b,

title = "Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasms",

author = "Gale, \{Robert Peter\} and Christophe Badie",

year = "2025",

month = apr,

doi = "10.1038/s41375-025-02544-3",

language = "English",

volume = "39",

pages = "1009--1010",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "4",

}

TY - JOUR

T1 - Commentary on the 2022 WHO Classification of Haematolymphoid Tumours

T2 - Myeloid and histiocytic/dendritic neoplasms

AU - Gale, Robert Peter

AU - Badie, Christophe

PY - 2025/4

Y1 - 2025/4

UR - https://www.scopus.com/pages/publications/105000522218

U2 - 10.1038/s41375-025-02544-3

DO - 10.1038/s41375-025-02544-3

M3 - Letter

AN - SCOPUS:105000522218

SN - 0887-6924

VL - 39

SP - 1009

EP - 1010

JO - Leukemia

JF - Leukemia

IS - 4

ER -

Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasms

UN SDGs

Access to Document

Other files and links

Cite this